Publications

Publications by the Clinical Breast Care Project  (Past 5 years)

Liu J, Lichtenberg T, Hoadley K, Cherniack A, Poisson L, Kovatich A, Benz C, Thorsson V, PanCanAtlas Network, Shriver CD, Hu H. “Using the new Pan-Cancer Clinical Data Resource (TCGA-CDR) to identify breast cancergenomic correlates associating with different survival outcome endpoints.” Ready to be submitted to DRP for publication clearance on 15 June 2017 to be presented at the 2017 San Antonio Breast Cancer Symposium.

Raj-Kumar PK, Liu J, Kovatich AJ, Kvecher L, Shriver CD, Hu H. “Use of principal component analyses to select ER-balanced subset for gene centering in PAM50 subtyping.” Ready to be submitted to DRP for publication clearance on 15 June 2017 to be presented at the 2017 San Antonio Breast Cancer Symposium.

Kumar AP, Kovatich AJ, Biancotto A, Cheung F, Davidson-Moncada JK, Kvecher L, Liu J, Ru Y, Kovatich AW, Deyarmin B, Fantacone-Campbell JL, Hooke JA, Raj Kumar PK, Rui H, Hu H, Shriver CD. “Analysis of breast cancer recurrence using gene set enrichment analysis.” Ready to be submitted to DRP for publication clearance on 15 June 2017 to be presented at the 2017 San Antonio Breast Cancer Symposium.

Lovejoy LA, Shriver CD, Ellsworth RE. “Assessment of the hereditary component in 94 cancer predisposition genes to triple negative breast cancer.” Submitted to DRP for publication clearance on 23 May 2017.

Eaglehouse YL, Shao S, Chan W, Brown D, Manjelievskaia J, Shriver CD, Zhu K. “The continuum of breast cancer care and outcomes in the U.S. Military Health System: an analysis by benefit type and care source.” Publication clearance received on 23 May 2017 to be presented at the 2017 Military Health System Research Symposium.

Raj Kumar PK, Liu T, Sturtz LA, Kovatich AJ, Gritsenko MA, Petyuk VA, Deyarmin B, Sridhara V, Craig J, McDermott JE, Shukla AK, Moore RJ, Monroe ME, Webb-Robertson BM, Hooke JA, Fantacone-Campbell L, Kvecher L, Liu J, Kane J, Melley J, Somiari S, Iida J, Benz SC, Golovato J, Rabizadeh S, Soon-Shiong P, Smith RD, Mural RJ, Rodland KD, Shriver CD, Hu H. “Differential exon usage in the HER2 subtype of breast cancer identified with RNA-seq and proteomic data.” American Association for Cancer Research Annual Meeting, 2017 Apr 1-5, Washington, D.C.

Sridhara V, Liu T, Gritsenko, MA, Sturtz LA, Kovatich AJ, Petyuk VA, Deyarmin B, McDermott JE, Shukla AK, Moore RJ, Monroe ME, Webb-Robertson BM, Hooke JA, Fantacone-Campbell L, Raj Kumar PK, Kvecher L, Liu J, Kane J, Melley J, Somiari S, Iida J, Benz SC, Golovato J, Rabizadeh S, Soon-Shiong P, Smith RD, Mural RJ, Shriver CD, Hu H, Rodland KD. “Integrated proteogenomic analysis of laser capture microdissected breast tumors.” American Association for Cancer Research Annual Meeting, 2017 Apr 1-5, Washington, D.C.

Costantino N, Shriver CD, Ellsworth RE. “Effects of smoking on breast tumor pathology.” Presented at the American Association for Cancer Research Annual Meeting, 2017 Apr 1-5, Washington, D.C.

Manjelievskaia J, Brown D, Shao S, Hofmann K, Shriver CD, Zhu K. “Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis Among DoD Beneficiaries.” Military Medicine 182(3): March 2017.

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth, RE. “Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node “Soil” Localized or Systemic?” Breast Cancer: Basic and Clinical Research 10 Feb 2017.

Costantino NS, Cox TM, Shriver CD, Ellsworth RE. “Lifestyle and Reproductive Factors Associated with Breast Cancer Risk in Young Women.” EC Gynaecology 4(2): 36-45. 08 Feb 2017.

Rummel SK, Shriver CD, and Ellsworth RE.  Contribution of germline mutations in cancer predisposition genes to tumor etiology in women diagnosed with invasive breast cancer before 40 years.  San Antonio Breast Cancer Symposium, 2016 Dec 6-12, San Antonio, TX.

Iida J, Dorchak J, Slavik J, Clancy R, Cutler ML, Shriver CD.  NEDD9 promotes breast cancer metastasis by regulating mitochondrial functions.  San Antonio Breast Cancer Symposium, 2016 Dec 6-12, San Antonio, TX.

Huo D, Hu H, Rhie SK, Gamazon EG, Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Ru Y, Lichtenberg T, Sturtz L, Laird PW, Shriver CD, Perou CM and Olopade OI.  Comprehensive Comparison of Breast Cancer Molecular Portraits between Black and White Patients in The Cancer Genome Atlas.  San Antonio Breast Cancer Symposium, 2016 Dec 6-12, San Antonio, TX.

Lovejoy L, Constantino N, Shriver CD, Ellsworth RE.  Relationship between obesity and breast tumor pathology in a contemporary set of patients.  San Antonio Breast Cancer Symposium, 2016 Dec 6-12, San Antonio, TX.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.  Robustness of quantitative immunohistochemistry: benchmark validation of two distinct automated immunofluourescence image analysis platforms.  San Antonio Breast Cancer Symposium, 2016 Dec 6-12, San Antonio, TX.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.  Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms. Mod Pathol.  2016 Oct;29(10):1143-54.

Costantino NS, Cox TM, Shriver CD, Ellsworth RE.  Lifestyle and reproductive factors associated with breast cancer risk in young women. WRNMMC publication clearance approval, 31 October 2016.

Blackburn, HL, Ellsworth, DL, Shriver CD, Ellsworth RE.  Breast cancer metastasis to the axillary lymph nodes: are changes to the lymph node “soil” localized or systemic?  WRNMMC publication clearance approval, 31 October 2016.

Costantino NS, Shriver CD, Ellsworth RE.  Effects of smoking on breast tumor pathology.  WRNMMC publication clearance approval, 25 October 2016.

Liu J, Kovatich AJ, Hooke JA, Campbell-Fantacone JL, Kvecher L, Sturtz LA, Shriver CD, and Hu H.  Race is not a contributing factor to breast cancer-free interval outcome for patients treated at the Walter Reed National Military Medical Center.  2016 Military Health System Research Symposium, 2016 Aug 15-18, Kissimmee, FL.

Ellsworth RE, Blackburn HL, Shriver CD, Soon-Shiong P, Ellsworth DL.  Molecular heterogeneity in breast cancer: state of the science and implications for patient care.  Semin Cell Dev Biol.  2016 Aug 26. pii: S1084-9521(16)30266-X.

Constantino N, Freeman B, Shriver CD, Ellsworth RE.  Outcome disparities in African American compared to European American women with ER+HER2- tumors treated within an equal-access health care system.  Ethnicity and Disease, 2016 Jul 21; 26(3):407-16.

Sabino J, Lucas DJ, Shriver CD, Vertrees AE, Valerio IL, Singh DP.  NSQIP analysis: increased immediate reconstruction in the treatment of breast cancer. Am Surg. 2016 Jun;82(6):540-5.

Brown D, Shao S, Jatoi I, Shriver CD, Zhu K.  Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.  Cancer Epidemiol.  2016 Jun; 42:24-31.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, and Rui H. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.  Mod Pathol. 2016 Jun 17.

Schwartzberg BS, Abdelatif O, Lewin J, Bernard J, Bu-Ali H, Cawthorn S, Chen-Seeto M, Feldman SM, Govindarajulu S, Jones L, Juette A, Kavia S, Maganini R, Pain S, Shere M, Shriver CD, Smith S, Valencia A, Whitacre EB, and Whitney R.  Multicenter, phase II open-label trial of percutaneous laser ablation (PLA) for 61 patients (PTS) with early-stage (ES) primary breast cancer: radiographic (MRI) and pathological correlation.”  J Clin Oncol 34, 2016 (suppl; abstr e12525).  Published in conjunction with the American Society of Clinical Oncology (ASCO) Annual Meeting, 3-7 Jun 2016, Chicago, IL.

Toro AL, Costantino NS, Shriver CD, Ellsworth DL, and Ellsworth RE.  Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients.  BMC Obes. 2016 Apr 29:3:22.

Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. Oncogene. 2016 Mar 17;35(11):1373-85. doi: 10.1038/onc.2015.193.  Epub 2015 Jun 22.

Rummel, SK, Ellsworth RE.  The role of histoblood ABO group in cancer.  Future Science OA.  2016 Mar 15.  FSO107.

Iida J, Bell-Loncella ET, Purazo ML, Lu Y, Dorchak J, Clancy R, Slavik J, Cutler ML, Shriver CD. Inhibition of cancer cell growth by ruthenium complexes. J Transl Med. 2016 Feb 12;14(1):48. doi: 10.1186/s12967-016-0797-9.

Costantino N, Toro AL, Shriver CD, Ellsworth DL, Ellsworth RE.  “Can a diagnosis of invasive breast cancer effectively motivate patients to follow a healthy lifestyle?”  San Antonio Breast Cancer Symposium, San Antonio, TX, 8-15 DEC 2015.

Toro AL, Costantino NS, Shriver CD, Ellsworth DE, Ellsworth R.  “Effect of obesity on molecular characteristics of invasive breast tumors; gene expression analysis of 405 tumors by BMI.”  San Antonio Breast Cancer Symposium, San Antonio, TX, 8-15 DEC 2015.

Ru Y, Hu PT, Kovatich AJ, Hooke JA, Jianfang L, Kvecher L, Fantacone-Campbell  JL, Deyarmin B, Kovatich AW, Cammarata F, Rui H, Shriver CD, Hu H. “CD163 expression is associated with young age, triple negative subtype, and poor outcome in breast cancer.”  San Antonio Breast Cancer Symposium, San Antonio, TX, 8-15 DEC 2015.

Iida J, Dorchak J, Clancy R, Slavik J, Cutler M, Shriver C,  “Tumor-associated glycans as key molecules to promote triple-negative breast cancer cells.”  San Antonio Breast Cancer Symposium, San Antonio, TX, 8-15 DEC 2015.

Craig J, Kovatich AJ, Hooke JA, Kvecher L, Liu J, Fantacone-Campbell JL, Rui H, Shriver CD, Hu H.  “PhosphohistoneH3 as a prognostic marker in breast cancer: high expression is associated with younger age, triple negative subtype, and disease specific survival.”  San Antonio Breast Cancer Symposium, San Antonio, TX, 8-15 DEC 2015.

Constantino N, Freeman B, Shriver CD, Ellsworth RE.  “Outcome disparities in African American compared to European American women with ER+HER2- tumors treated within an equal-access health care system.”  Submitted for publication in the journal, Ethnicity and Disease, 20 Nov 2015.

Kovatich AJ, Chen Y, Hooke JA, Kvecher L, Liu J, Bekhash A, Maskery S, Fantacone-Campbell JL, Ru Y, Rui H, Mural RJ, Shriver CD, Hu H.  “Subtype-specific co-occurrence of atypical hyperplasia and in situ carcinoma with invasive breast cancers.”  Submitted for publication in the journal, Cancer Epidemiology, Biomarkers and Prevention, 18 Nov 2015.

Toro AL, Hueman MT, Shriver CD, Ellsworth RE.  “Epidemiological factors associated with breast cancer in young women.”  Submitted for WRNMMC publication approval 6 Nov 2015.

Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA, TCGA Research Network, Perou CM.  “Comprehensive molecular portraits of invasive lobular breast cancer.”  Cell. 2015 Oct 8;163(2):506-19.

Valente AL, Schroeder B, Shriver CD, Henning JD, Ellsworth RE.  “Chronic inflammation in cancer: the role of human viruses.”  Advances in Tumor Virology 2015(5):1-11.

Barrow TM, Barault L, Ellsworth RE, Harris HR, Binder AM, Valente AL, Shriver CD, Michels KB.  “Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer.”  International Journal of Cancer.  2015 August 1:137(3): 537-47.

Ellsworth RE, Toro AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula KA, Costantino NS, Hooke JA, Shriver CD, Ellsworth DL.  “Molecular heterogeneity in primary breast carcinomas and axillary lymph node metastases assessed by genomic fingerprinting analysis.”  Cancer Growth Metastasis.  2015 July 20(8):15-24.

Rummel SK, Hueman MT, Costantino N, Shriver CD, Ellsworth RE.  “Tumor location within the breast: does tumor site have prognostic ability?” eCancermedicalscience, 2015 July 13(9):552.

Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE.  “Management of incidental findings in the era of next-generation sequencing.”  Current Genomics.  2015 June; 16(3): 159-74.

Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H.  “Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.”  Oncogene.  2015 June 22. 

Chen Y, Bekhash A, Kovatich AJ, Hooke JA, Liu J, Kvecher L, Fantacone-Campbell JL, Mitchell EP, Rui H, Mural RJ, Shriver CD, Hu H.  “Positive association of fibroadenomatoid change with HER2-negative invasive breast cancer: a co-occurrence study.”  PLoS One.  2015 June 22;10(6):e0129500.

Toro AL, Constantino NS, Shriver, CD, Ellsworth, DL, Ellsworth, RE.  “Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis of 405 tumors by BMI.” (submitted for publication clearance May 2015).

Rummel SK, Yarina W, Toro AL, Shriver CD, Ellsworth RE. “Differential gene expression in breast tumors from African American women: separating causation from stratification.” (submitted for publication clearance May 2015).

Rummel SK, Hueman MT, Costantino N, Shriver CD, Ellsworth RE.  “Association of tumor location within the breast and clinicopathological characteristics.”  American Association for Cancer Research, Annual Meeting, April 18-22, 2015, Philadelphia, PA.

Ellsworth RE, Mamula KA, Costantino NS, Deyarmin B, Kostyniak PJ, Chi LH, Shriver CD, Ellsworth DL.  “Abundance and distribution of polychlorinated biphenyls (PCBs) in breast tissue.”  Environmental Research.  2015 April;138: 291-7.

Constantino N, Toro AL, Shriver CD, Ellsworth EL, Ellsworth RE.  “Can a diagnosis of invasive breast cancer effectively motivate patients to follow a healthy lifestyle?” (submitted for publication clearance April 2015).

Iida J, Elisabeth T, Bell-Loncella TB, Purazo ML, Lu Y, Dorchak J, Clancy R, Slavick J, Ferrone S, Cutler ML, Shriver CD.  “Inhibition of cancer cell growth by ruthenium complexes.” (submitted for publication clearance March 2015).

Shriver CD, Hueman MT, Ellsworth RE. “Avoidance of surgical disruption of the axillary lymph nodes: can molecular profiling of primary breast tumors predict lymph node status?” Society of Surgical Oncology Annual Meeting, March 25-28, 2015, Houston, TX.

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE. “Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism and response to endocrine therapy.”  Cancer Causes and Control.  2015 March; 26(3):319-32.

Shriver CD, Hueman MT, Ellsworth RE.  “Avoidance of sentinel lymph node biopsy: can molecular profiling of primary breast tumors predict lymph node status?”  Society of Surgical Oncology Annual Cancer Symposium, March 25-28, 2015, Houston, TX.

Ellsworth RE, Valente AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula K, Shriver CD, Ellsworth DL.  “Effect of genomic heterogeneity on breast cancer progression and metastatic spread.”  Society of Surgical Oncology Annual Cancer Symposium, March 25-28, 2015, Houston, TX.

Iida J, Dorchak J, Clancy R, Slavik J, Ellsworth R, Katagiri Y, Pugacheva EN, van Kuppevelt TH, Mural RJ, Cutler ML, Shriver CD.  “Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth.”  Experimental Cell Research.  2015 Jan 15; 330(2):358-70.

Yarina WC, Field LA, Deyarmin B, van Laar R, Hooke JA, Shriver CD, Ellsworth RE.  “Molecular characterization of breast tumor-associated adipose.”  Cancer Research. 1 Jan 2015 75; B49.

Ellsworth RE, Valente AL, Hueman MT, Shriver CD.  “Pathological and molecular effects of lack of PR expression in ER positive breast tumors.”  Cancer Research. 1 May 2015 75; P3-04-12.  Annual CTRC-AACR San Antonio Breast Cancer Symposium; Dec 9-13, 2014, San Antonio, TX.

Shriver CD, Hueman MT, Ellsworth RE.  “Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes.”  Journal of Experimental Clinical Cancer Research.  2014 Dec 31;33(1):782.

Ru Y, Mural R, Steeg PS, Rui H, Shriver CD, Hu H.  “Age independently predicts worse disease-specific survival in patients diagnosed with invasive breast cancers at 50 years of age or older but not younger.”  Annual CTRC-AARC San Antonio Breast Cancer Symposium, Dec 9-13, 2014, San Antonio, TX.

Ru Y, Lin J, Campbell JL, Zhu K, Kovatich AJ, Hooke JA, Kvecher L, Deyarmin B, Kovatich AW, Cammarata F, Rui H, Mural RJ, Shriver CD, Hu H.  “Survival comparative analysis of patients with invasive breast cancer treated by a military medical center and matched patients of the U.S. general population.”  Annual CTRC-AARC San Antonio Breast Cancer Symposium, Dec 9-13, 2014, San Antonio, TX.

Iida J, Purazo ML, Li Y, Bell-Loncella ET, Shriver CD.  “Structure-activity relationship of ruthenium (Ru) complexes to inhibit breast cancer growth and metastasis.”  Annual CTRC-AARC San Antonio Breast Cancer Symposium, Dec 9-13, 2014, San Antonio, TX.

Henning J, Oakes N, Valente AL, Deyarmin B, Meyer J, Hueman MT, Shriver CD, Ellsworth RE.  “Evaluation of the role of EBV in breast cancer.”  Annual CTRC-AARC San Antonio Breast Cancer Symposium, Dec 9-13, 2014, San Antonio, TX.

Joseph N, Kvecher L, Deyarmin B, Sturz L, Cammarata F, Larson C, Shriver CD, Mural RJ, Hu H.. “Tissue-experiment inventory: a system to enable cataloguing of experimental results in association with tissue and participant information.” American Medical Informatics Association (AMIA) Annual Symposium, Nov 15-19, 2014, Washington, DC.

Cammarata FJ, Kvecher L, Rui H, Kovatich AJ, Campbell LF, Hooke JA, Joseph NP, Shriver CD, Mural RJ, Hu H.  “A data repository system for translational research.” American Medical Informatics Association (AMIA) Annual Symposium, Nov 15-19, 2014, Washington, DC.

Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD, Zhu K. “Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the surveillance, epidemiology and end results data.” Cancer Causes and Control. 2014 Aug; 25(8):959-68.

Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD, Zhu K. “Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology and End Results data.”  Cancer Causes Control. 2014 Aug; 25(8):959-68. Doi: 10.1007/s10552-014-0395-1.

Valente AL, Rummel S, Shriver CD, Ellsworth RE. “Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast.”  Hered Cancer Clin Pract. 2014 Jul 19; 12(1):17. Doi:10.1186/1897-4287-12-17.

Enewold LR, McGlynn KA, Zahm SH, Poudrier J, Anderson WF, Shriver CD, Zhu K. “Breast reconstruction after mastectomy among Department of Defense beneficiaries by race.” Cancer. 2014 Jun 25. Doi: 10.1002/cncr.28806.

Valente AL, Kane JL, Ellsworth DL, Shriver CD, Ellsworth RE. “Molecular response of the axillary lymph node microenvironment to metastatic colonization.” Clin Exp Metastasis. 2014 Jun;31(5):565-72. doi: 10.1007/s10585-014-9650-9.

Sturtz LA, Deyarmin B, van Laar R, Yarina W, Shriver CD, Ellsworth RE. “Gene expression differences in adipose tissue associated with breast tumorigenesis.” Adipocyte. 2014 Apr 1;3(2):107-14. doi: 10.4161/adip.28250.

Valente AL, Shriver CD, Ellsworth RE. “Gene expression profiling of breast tumors from African American and Caucasian women: are molecular differences meaningful?” American Association for Cancer Research Annual Meeting, April 2014.

Gallagher C, More K, Hu H, Sicignano N, Masaquel A, Kamath T, Brammer M, Shriver CD, Goehring E, Kapasi A, Jones J. “Discordance rate between two tests used to diagnose patients with HER2-overexpressing breast cancer.” AMCP Conference, 1-4 April 2014, Tampa, FL.

Rummel S, Penatzer CE, Shriver CD, Ellsworth RE. “PSPHL and breast cancer in African American women: causative gene or population stratification?”  BMC Genet. 2014 Mar 20;15:38. doi: 10.1186/1471-2156-15-38.

Maskery S, Bekhash A, Kvecher L, Correll M, Hooke JA, Kovatich AJ, Shriver CD, Mural RJ, and Hu H. “Aggregated biomedical-information browser (ABB): a graphical user interface for clinicians and scientists to access a clinical data warehouse” Journal of Computer Science & Systems Biology. February 2014.

Iida J, Clancy R, Dorchak J, Somiari RI, Somiari S, Cutler ML, Mural RJ, Shriver CD.  “DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.” PLoS One. 2014 Feb 19;9(2):e88712. doi: 10.1371/journal.pone.0088712.

Greenspan R, O’Donnell A, Meyer J, Kane J, Mamula K, Deyarmin B, Larson C, Rigby S, Sturz LA, Lelley J, Shriver CD, Ellsworth RE. “Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer” BMC Cancer. 2014 February 2014.

Sturtz LA, Melley J, Mamula K, Shriver CD, Ellsworth RE. “Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.” BMC Cancer. 2014 Feb 4;14:62.

Greer LT, Rosman M, Charles Mylander W, Liang W, Buras RR, Chagpar AB, Edwards MJ, Tafra L. “A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women” Breast Journal, 30 January 2014.

Kovatich AJ, Chen Y, Fantacone-Campbell JL, Wareham JA, Tafra L, Kvecher L, Hyslop T, Hooke JA, Rui H, Shriver CD, Mural RJ, Hu H.  “Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient” SABCS, 11-14 December 2013, San Antonio, TX.

Chen Y, Kovatich AJ, Fantacone-Campbell JL, Hooke JA, Kvecher L, Kovatich AW, Gallagher CM, Mural RJ, Shriver CD, Rui H, Hu H.  “Her2-positive and Her2-negative luminal B subtypes have similar overall survival and histologic grade distributions” SABCS, 11-14 December 2013, San Antonio, TX.

Li R, Campos J, Chen Y, Kvecher L, Gdula D, Hoadly K, Shriver CD, Mural RJ, Hu H.  “Highly variably expressed exons (HVEE) of cancer genes and survival disparity in human breast cancer” SABCS, 11-14 December 2013, San Antonio, TX.

Kovatich AJ, Chen Y, Fantacone-Campbell JK, Wareham JA, Tafra L, Kvecher L, Hyslop t, Hooke JA, Shriver CD, Mural RJ, Hu H.  “Cell proliferation marker Ki67 is expressed more in core biopsies than surgically resurrected tumors from invasive breast cancer patients” SABCS, 11-14 December 2013, San Antonio, TX.

Field LA, Melley J, Mamula K, Means M, Shriver CD, Ellsworth RE.  “Evaluation of epidemiological and molecular differences in African American and Caucasian women with triple negative breast cancer” SABCS, 11-14 December 2013, San Antonio, TX.

Ellsworth RE, Valente AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula KA, Shriver CD, Ellsworth DL.  “Effect of genomic heterogeneity on breast cancer progression and metastatic spread” SABCS, 11-14 December 2013, San Antonio, TX.

Maskery S, Bekhash A, Kvecher L, Correll M, Hooke JA, Kovatich AJ, Shriver CD, Mural RJ.  “Aggregated biomedical information browser (ABB): a graphical user interface for clinicians and scientists to access a clinical data warehouse” AIMA Annual Symposium, 16-20 November 2013, Washington DC.

Brown S, Shriver CD, Ellsworth RE.  “Role of rs9620497 with CRYBB2 expression levels in African American women with invasive breast cancer” ASHG, 22-26 October 2013, Boston, MA.

Valente AL, Shriver CD, Ellsworth RE.  “Gene expression profiling of breast tumors from African American and Caucasian women: are molecular differences meaningful?”  AACR Advances in Breast Cancer Research Conference, 3-6 October 2013, San Diego, CA.

Field L, Deyarmin B, van Laar R, Shriver CD, Ellsworth RE.  “Identification of gene expression profiles associated with different types of breast adipose and their relationship to tumorigenesis” AACR Advances in Breast Cancer Research Conference, 3-6 October 2013, San Diego, CA.

Enewold L, McGlynn KA, Zahm SH, Jatoi I, Anderson WF, Gill AA, Shriver CD, Zhu K. “Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity.” Cancer. 2013 Oct 1; 119(19): 3531-8. doi: 10.1002/cncr.28242.

Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H.  “Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment” Breast Cancer Research, 3 September 2013.

Zhou J, Enewold L, Zahm SH, Jatoi I, Shriver C, Anderson WF, Jeffery DD, Andaya A, Potter JF, McGlynn KA, Zhu K. “Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care system.”  Am J Surg. 2013 September; 206(3):393-9. doi: 10.1016/j.amjsurg.2013.01.034.

Rummel S, Penatzer CE, Shriver CD, Ellsworth RE. “PSPHL and breast cancer in African American women: causative gene or population stratification?” Cancer Research, August 2013.

Ellsworth RE, Valente AL, Kane JL, Ellsworth DE, Shriver CD.  “Molecular response of the axillary lymph node microenvironment to metastatic colonization” Cancer Research, August 2013.

Milburn M, Rosman M, Mylander C, Tafra L. “Is oncotype DX recurrence score (RS) of prognositic value once HER2-positive and low-ER expression patients are removed?” Breast Journal, July-August 2013.

Ellsworth RE, Penatzer C, Shriver CD.  “Demographic and pathological differences between women treated in rural compared to urban-military breast cancer centers”   ASCO, 31 May-4 June 2013.

Sato T, Tran TH, Peck AR, Girondo MA, Liu C,  Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H.  “Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer by a mechanism that involves inhibition of progestin-driven BCL6 expression”  Oncogene Journal, 27 May 2013.

Barrow, TM, Barault L, Ellsworth RE, Harris HR, Valente AL, Shriver CD, Michels KB.  “Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer”  Gordon Research Conferences: Cancer Genetics and Epigenetics, 21-26 April 2013, Lucca (Barga), Italy.

Greenspan R, O’Donnell A, Meyer J, Kane J, Mamula K, Deyarmin B, Larson C, Rigby S., Greenawalt A, Vatanian N, Mural R, Shriver C, Somiari S.  “Tissue imprints and scrapings: assessing their potential as routine biobanking specimens for molecular research”  Biopreservation and Biobanking Journal, submitted for publication April 2013.

Barrow TM, Ellsworth RE, Harris H, Barault L, Velente A, Shriver CD, Michels KB.  “Loss of imprinting in PEG3, MEST and ARHI/DIRAS3 in invasive breast cancer”   AACR, 6-10 April 2013, Washington, DC.

Rummel S, Penatzer C, Shriver CD, Ellsworth RE.  “PSPHL and breast cancer in African American women: causative gene or population stratification?”   AACR, Washington, DC, 6-10 April 2013.

Barrow TM, Barault L, Ellsworth RE, Harris HR, Valente AL, Shriver CD, Michels KB.  “Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer”  Dana Farber Harvard Cancer Center, Breast and Gynecological Cancers symposium, 22 March 2013, Boston, MA.

Barault L, Ellsworth RE, Harris HR, Valente AL, Shriver CD, Michels KB. “Leukocyte DNA as surrogate for the evaluation of imprinted loci methylation in mammary tissue DNA”  PLOS ONE, 7 Feb 2013.

Rummel S, Varner E, Shriver CD, Ellsworth RE.  “Evaluation of BRCA1 mutations in an unselected patient population with triple negative breast cancer”  Breast Cancer Research and Treatment, Jan 2013.

Ellsworth RE, Valente AL, Shriver CD.  “The effect of HER2 expression on luminal A breast tumors”  SABCS, 4-8 Dec 2012, San Antonio, TX.

Field L, Deyarmin B, van Laar R, Hooke J, Shriver C, Ellsworth R.  “Molecular characteristics of breast tumor-associated adipose”  SABCS, San Antonio, TX 4-8 Dec 2012.

Kovatich AJ, Luo C, Chen Y, Hooke JA, Kvecher L, Rui H, Shriver CD, Mural RJ, Hu H. “Molecular subtypes of invasive breast cancers show differential expression of the proliferation marker Aurora Kinase A (AURKA)”  SABCS, San Antonio, TX 4-8 Dec 2012.

Chen Y, Bekhash A, Kovatich AJ, Hooke JA, Kvecher L, Mitchell EP, Rui H, Mural RJ, Shriver CD, Hu H.   “Fibroadenomatoid changes are more prevalent in middle-aged women and have a positive association with invasive breast cancer” SABCS, San Antonio, TX  4-8 Dec 2012.

Luo C, Iida J, Chen Y, Dorchak J, Kovatich AJ, Mural RJ, Hu H, Shriver CD.  “Higher gene expression of CSPG4 in the basal-like subtype of invasive breast cancer and its negative association with lymph node metastasis”   SABCS, San Antonio, TX 4-8 Dec 2012.

Luo C, Chen Y, Kovatich AJ, Hooke JA, Kvecher L, Shriver CD, Mural RJ, Hu H.  “p53 gene and protein expression patterns in human invasive breast cancers are correlated with its mutation status”  SABCS, San Antonio, TX 4-8 Dec 2012.

Dorchak J, Iida J, Clancy R, Luo C, Chen Y, Hu H, Mural RJ, Shriver CD.  “FH535 inhibited migration and growth of breast cancer cells” SABCS, San Antonio, TX 4-8 Dec 2012.

Luo C, Chen Y, Shriver CD, Hu H, Mural RJ.  “Breast cancer subtype distribution among HapMap classified ethnic groups”  SABCS, San Antonio, TX 4-8 Dec 2012.

Valente AL, Kane JL, Ellsworth DL, Shriver CD, Ellsworth RE.  “Molecular response of the axillary lymph node microenvironment to metastatic colonization” AACR, 4-8 Dec 2012, San Antonio, TX.

Barrow TM, Barault L, Ellsworth RE, Harris HR, Valente AL, Shriver CD, Michels KB.  “Aberrant methylation of imprinted genes is associated with triple-negative hormone receptor status in invasive breast cancer”  Max Planck Freiburg Epigenetics Meeting, 5-8 Dec 2012, Freiburg, Germany.

Iida J, Dorchak J, Clancy R, Luo C, Chen Y, Hu H,  Mural RJ, Shriver CD.  “CSPG4-NEDD9 interaction promotes migration, invasion, and growth of breast cancer cells”  ASCB, San Francisco, CA, 15-19 Dec 2012.

Rummel SE, Shriver CD, Ellsworth RE.  “ Evaluation of BRCA1 mutations in patients with family history of breast cancer”  ASHG, 6-10 Nov 2012, San Francisco, CA.

Valente AL, Rummel S, Shriver CD, Ellsworth RE   “CDH1 mutations in patients with lobular carcinoma of the breast”  ASHG, 6-10 Nov 2012, San Francisco, CA.

Ellsworth RE and Shriver CD.   “Demographic differences in African American compared to Caucasian women with luminal A breast cancer”  AACR, San Diego, CA, 27-30 Oct 2012.

Shriver CD and Mural RJ.  “Prestigious Journal to Publish Collaborative Breast Cancer Research” HJF newsletter 'SCOOP', Oct 2012.

Collaborators  (The Cancer Genome Atlas-Breast Cancer Project Team).  “Comprehensive molecular portraits of human breast tumors”  Nature, 4 Oct 2012;490(7418);61-70.

Voeghtly LM, Mamula K, Campbell JL, Shriver CD, Ellsworth RE.  “Molecular alterations associated with early and late breast cancer mortality”  PLOS ONE, 4 Oct 2012.

Greer LT, Rosman M, Mylander W, Wareham  J, Campbell JL, Hooke J, Kovatich A, Shriver CD,  Tafra L.  “Should immunohistochemical (IHC) markers be performed on axillary lymph node metastases in view of the lack of concordance between the primary tumor and axillary lymph node metastases?”  American College of Surgeons 98th Annual Clinical Congress, 30 Sep-4 Oct 2012, Chicago, IL.

Iida J, Dorchak J, Lehman JR, Clancy R, Luo C, Chen Y, Somiari S, Ellsworth RE, Hu H, Mural RJ, Shriver CD.  “FH535 inhibited migration and growth of breast cancer cells” PLOS ONE, 11 Sept 2012.

Greer LT, Rosman M, Mylander WC, Hooke J, Kovatich A, Sawyer K, Buras R, Shriver CD, Tafra L.  “Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens?” Association of Women Surgeons (AWS), September 2012, Chicago, IL, in conjunction with the American College of Surgeons 98th Annual Clinical Congress.

Shriver CD.  “A biomedical informatics infrastructure to support translational research” NCI Center for Biomedical Informatics & Information Tech Speaker Series, 5 Sep 2012.